As per corporate shareholdings filed for Jun-2025, people matching AZ Fd1 AZ Equity - Biotechnology publicly holds 63 stocks with a net worth of over US$ 44.6 M.
These are shares held by AZ Fd1 AZ Equity - Biotechnology as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc | Az Fd1 Az Equity - Biotechnology | 131.87 | 4,648 | 0.00% | 0.00 | 612.9 K | ||
| Blueprint Medicines Corp | Az Fd1 Az Equity - Biotechnology | 129.46 | 5,512 | 0.01% | 0.00 | 713.6 K | ||
| Argen X SE - ADR | Az Fd1 Az Equity - Biotechnology | 663.73 | 2,089 | 0.00% | 0.00 | 1.4 M | ||
| Astrazeneca plc - ADR | Az Fd1 Az Equity - Biotechnology | 80.46 | 30,727 | 0.00% | 0.00 | 2.5 M | ||
| Gilead Sciences, Inc. | Az Fd1 Az Equity - Biotechnology | 116.14 | 32,834 | 0.00% | 0.00 | 3.8 M | ||
| Incyte Corp. | Az Fd1 Az Equity - Biotechnology | 86.53 | 19,739 | 0.01% | 0.00 | 1.7 M | ||
| Insmed Inc | Az Fd1 Az Equity - Biotechnology | 132.60 | 12,805 | 0.01% | 0.00 | 1.7 M | ||
| Ionis Pharmaceuticals Inc | Az Fd1 Az Equity - Biotechnology | 43.24 | 26,580 | 0.02% | 0.00 | 1.1 M | ||
| Neurocrine Biosciences, Inc. | Az Fd1 Az Equity - Biotechnology | 135.28 | 10,750 | 0.01% | 0.00 | 1.5 M | ||
| Regeneron Pharmaceuticals, Inc. | Az Fd1 Az Equity - Biotechnology | 598.16 | 3,127 | 0.00% | 0.00 | 1.9 M | ||
| Verona Pharma Plc - ADR | Az Fd1 Az Equity - Biotechnology | 105.45 | 12,703 | 0.01% | 0.00 | 1.3 M | ||
| Vertex Pharmaceuticals, Inc. | Az Fd1 Az Equity - Biotechnology | 397.46 | 7,036 | 0.00% | 0.00 | 2.8 M | ||
| Arbutus Biopharma Corp | Az Fd1 Az Equity - Biotechnology | 3.58 | 68,991 | 0.04% | 0.00 | 247.0 K | ||
| Abivax - ADR | Az Fd1 Az Equity - Biotechnology | 74.43 | 44,756 | 0.06% | -0.01 | 3.3 M | ||
| Agios Pharmaceuticals Inc | Az Fd1 Az Equity - Biotechnology | 38.20 | 10,163 | 0.02% | 0.00 | 388.2 K | ||
| Alnylam Pharmaceuticals Inc | Az Fd1 Az Equity - Biotechnology | 467.55 | 1,955 | 0.00% | 0.00 | 914.1 K | ||
| AMGEN Inc. | Az Fd1 Az Equity - Biotechnology | 295.76 | 3,322 | 0.00% | 0.00 | 982.5 K | ||
| Annexon Inc | Az Fd1 Az Equity - Biotechnology | 2.17 | 80,521 | 0.07% | 0.00 | 174.7 K | ||
| Apogee Therapeutics Inc. | Az Fd1 Az Equity - Biotechnology | 36.35 | 12,703 | 0.02% | 0.00 | 461.8 K | ||
| Arcturus Therapeutics Holdings Inc | Az Fd1 Az Equity - Biotechnology | 17.48 | 13,681 | 0.05% | 0.00 | 239.1 K | ||
| Arvinas Inc | Az Fd1 Az Equity - Biotechnology | 7.30 | 18,176 | 0.02% | 0.00 | 132.7 K | ||
| Ascendis Pharma A/S - ADR | Az Fd1 Az Equity - Biotechnology | 192.80 | 4,691 | 0.01% | 0.00 | 904.4 K | ||
| Atyr Pharma Inc | Az Fd1 Az Equity - Biotechnology | 4.95 | 25,212 | 0.03% | NEW | 124.8 K | ||
| Avadel Pharmaceuticals plc - ADR | Az Fd1 Az Equity - Biotechnology | 14.82 | 54,528 | 0.06% | 0.00 | 808.1 K | ||
| Axsome Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 117.14 | 8,795 | 0.02% | 0.00 | 1.0 M | ||
| Black Diamond Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 2.71 | 77,199 | 0.14% | 0.01 | 209.2 K | ||
| Biogen Inc | Az Fd1 Az Equity - Biotechnology | 139.12 | 5,277 | 0.00% | 0.00 | 734.1 K | ||
| BioNTech SE - ADR | Az Fd1 Az Equity - Biotechnology | 110.77 | 7,818 | 0.00% | 0.00 | 866 K | ||
| Capricor Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 7.02 | 23,843 | 0.05% | 0.00 | 167.4 K | ||
| Cullinan Oncology Inc | Az Fd1 Az Equity - Biotechnology | 7.67 | 14,267 | 0.02% | 0.00 | 109.4 K | ||
| Catalyst Pharmaceuticals Inc | Az Fd1 Az Equity - Biotechnology | 20.56 | 31,661 | 0.03% | 0.00 | 651.0 K | ||
| Cytokinetics Inc | Az Fd1 Az Equity - Biotechnology | 38.05 | 7,818 | 0.01% | 0.00 | 297.5 K | ||
| Day One Biopharmaceuticals Inc | Az Fd1 Az Equity - Biotechnology | 6.98 | 38,697 | 0.04% | 0.00 | 270.1 K | ||
| Design Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 5.15 | 17,590 | 0.03% | 0.00 | 90.6 K | ||
| Edgewise Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 14.62 | 26,971 | 0.03% | 0.00 | 394.3 K | ||
| Exact Sciences Corp. | Az Fd1 Az Equity - Biotechnology | 46.68 | 11,531 | 0.01% | 0.00 | 538.3 K | ||
| Halozyme Therapeutics Inc. | Az Fd1 Az Equity - Biotechnology | 71.61 | 6,840 | 0.01% | 0.00 | 489.8 K | ||
| Immunome Inc | Az Fd1 Az Equity - Biotechnology | 9.95 | 17,980 | 0.02% | 0.00 | 178.9 K | ||
| Inhibrx Biosciences Inc. | Az Fd1 Az Equity - Biotechnology | 24.16 | 17,394 | 0.12% | 0.01 | 420.2 K | ||
| Janux Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 24.00 | 6,840 | 0.01% | 0.00 | 164.2 K | ||
| Jazz Pharmaceuticals plc | Az Fd1 Az Equity - Biotechnology | 120.53 | 2,150 | 0.00% | 0.00 | 259.1 K | ||
| Krystal Biotech Inc | Az Fd1 Az Equity - Biotechnology | 145.70 | 4,691 | 0.02% | 0.00 | 683.5 K | ||
| Kymera Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 42.59 | 5,667 | 0.01% | 0.00 | 241.4 K | ||
| MeiraGTx Holdings plc | Az Fd1 Az Equity - Biotechnology | 7.85 | 41,238 | 0.05% | 0.00 | 323.7 K | ||
| NewAmsterdam Pharma Company NV | Az Fd1 Az Equity - Biotechnology | 24.44 | 16,026 | 0.01% | 0.01 | 391.7 K | ||
| Nurix Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 9.65 | 18,176 | 0.02% | 0.00 | 175.4 K | ||
| Intellia Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 10.12 | 15,831 | 0.01% | 0.00 | 160.2 K | ||
| Natera Inc | Az Fd1 Az Equity - Biotechnology | 161.95 | 1,955 | 0.00% | 0.00 | 316.6 K | ||
| Nuvalent Inc - Ordinary Shares - Class A | Az Fd1 Az Equity - Biotechnology | 73.65 | 6,450 | 0.01% | 0.00 | 475.0 K | ||
| Oruka Therapeutics Inc. | Az Fd1 Az Equity - Biotechnology | 14.79 | 15,831 | 0.04% | 0.00 | 234.1 K | ||
| Vaxcyte Inc | Az Fd1 Az Equity - Biotechnology | 31.91 | 7,818 | 0.01% | 0.00 | 249.5 K | ||
| Protagonist Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 56.04 | 12,508 | 0.02% | 0.00 | 700.9 K | ||
| Rapport Therapeutics Inc. | Az Fd1 Az Equity - Biotechnology | 14.93 | 13,161 | 0.04% | NEW | 196.5 K | ||
| Roivant Sciences Ltd | Az Fd1 Az Equity - Biotechnology | 11.81 | 65,277 | 0.01% | 0.00 | 770.9 K | ||
| Rhythm Pharmaceuticals Inc. | Az Fd1 Az Equity - Biotechnology | 101.68 | 9,967 | 0.02% | 0.00 | 1.0 M | ||
| Scholar Rock Holding Corp | Az Fd1 Az Equity - Biotechnology | 34.59 | 9,381 | 0.01% | 0.00 | 324.5 K | ||
| Tectonic Therapeutic Inc. | Az Fd1 Az Equity - Biotechnology | 25.40 | 2,541 | 0.01% | 0.00 | 64.5 K | ||
| Trevi Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 7.49 | 32,639 | 0.03% | 0.00 | 244.5 K | ||
| Viking Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 25.66 | 8,599 | 0.01% | 0.00 | 220.7 K | ||
| Verastem Inc | Az Fd1 Az Equity - Biotechnology | 8.63 | 33,030 | 0.05% | 0.00 | 285.0 K | ||
| VYNE Therapeutics Inc | Az Fd1 Az Equity - Biotechnology | 0.32 | 91,075 | 0.55% | 0.02 | 29.1 K | ||
| Wave Life Sciences Ltd. | Az Fd1 Az Equity - Biotechnology | 9.76 | 39,844 | 0.03% | NEW | 388.9 K | ||
| Xeris Biopharma Holdings Inc | Az Fd1 Az Equity - Biotechnology | 7.59 | 62,778 | 0.04% | 0.02 | 476.5 K | ||
| Compass Pathways Plc - ADR | 4.31 | - | Investor holds below 1% | |||||
| Rocket Pharmaceuticals Inc | 3.73 | - | Investor holds below 1% | |||||
| Ovid Therapeutics Inc | 0.96 | - | Investor holds below 1% | |||||
| Biohaven Ltd | 14.68 | - | Investor holds below 1% |